Use access key #2 to skip to page content.
$15.53 -0.28 (-1.77%)
9/8/2008 9:51 AM

Par Pharmaceutical Companies, Inc. (PRX)

CAPS Rating:
***

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

View All Commentary (PRX)

Recs

0

Avatar tikiskis (83.39) Submitted: 2/05/08 3:19 PM : Outperform Start Price: $19.48 PRX Score: -14.81

Two words will boost this company: baby boomers. That combined with a faling health care system that intentionally plunges people into poverty will make discount drugs the place to be.





Granted, the above is only a justification for why this niche INDUSTRY will be good in the long term. There are still legitimate concerns about the financials on this company. However, given its place in foreign markets and the risk factor for any pharma company (especially one undercutting the majors), this is a bet that I believe will pay off.

Report this Post Replies: 0 | Reply

Featured Broker Partners